You can find more information about
Transketolase
using the following links:
PFID
PFID Old
Formal Annotation
PlasmoDB
TDR Targets
Subcellular Localization
Affecting Drugs
Drug Name
PubMed Articles (year of publication)
PF3D7_0610800
PFF0530w
transketolase
PlasmoDB
TDR
(E)-1-(2,4-dinitrophenyl)-2-((10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-((R)-6-methylhept-5-en-2-yl)-1,2,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-ylidene)hydrazine
Structure based design, stability study and synthesis of the dinitrophenylhydrazone derivative of the oxidation product of lanosterol as a potential P. falciparum transketolase inhibitor and in-vivo antimalarial study
6'-Methyl-Thiamin Diphosphate
Molecular-docking study of malaria drug target enzyme transketolase in Plasmodium falciparum 3D7 portends the novel approach to its treatment
7-hydroxy-5-methyl-2-(2-oxopropyl)-8-((1S,2S,3R,4R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl)-4H-chromen-4-one
Characterisation of plasmodial transketolases and identification of potential inhibitors: an in silico study
Molecular biology, suggested target
Molecular cloning and characterization of Plasmodium falciparum transketolase
Expasy - NiceZime View
Brenda - The Comprehensive Enzyme Information System